Global Dengue Vaccine Market Outlook 2024: Global Opportunity And Demand Analysis, Market Forecast, 2016-2024

1. Vision Value Visibility Report Code :HC 1005 2016-2024 Global Dengue Vaccine Market Outlook 2024: Global Opportunity & Growth Analysis, 2016-2024 99 Wall Street, Suite No:- 527, New York, NY 10005 United States of America +1-646-568-7747 +1-437-886-1181 Office No:- 504, 5th Floor, C-51, BSI Business Park, Sector-62, Noida, PIN:- 201301 India  +44-203-318-6627 +91-120-473-0422, +91-844-785-9968 www.goldsteinresearch.com sales@goldsteinresearch.com Published By: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com

2. Executive Summary Sample Request Global Dengue Vaccine Market Share(%), By Region-2016-2024 Global Dengue Vaccine Market Size USD (Billion). 2016-2024 XX% CAGR: (2016-2024) Sample Source: Goldstein Research Source: Goldstein Research In 2016,Live Attenuated Vaccine accounted for the highest market share XX% in Dengue Vaccine Market WithXX%share in 2016, APACregion dominated the GlobalDengue Vaccine market Global Dengue Vaccine Market Share(%), By Technology-2016 Global Dengue Vaccine Market Share(%), By End Users-2016 Source: Goldstein Research Source: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com

3. Executive Summary Sample Request • In 2016, government institutions dominated the overall end-use segment in global dengue vaccine market; this segment accounted for nearly XX% of the total dengue vaccine market and remaining XX% went for other end end-use segment i.e. private institutions. The main reason for this despaired share is due to the government initiatives to eradicate dengue • However, as the vaccine technology is on rise (especially in developing regions), the global dengue vaccine market is projected to reach USD XXXX million in 2024 from USD XXXX million in 2016, registering a growth rate of XX%. In addition to that, dengue vaccines used in hospitals has touched USD XXXX million in 2016 and growing demand for dengue vaccines in government and private hospitals is expected to help the market to reach USD XXXX million by the end of 2024 • As a result, if seen from the big market point of view, dengue vaccine demand is higher in hospitals followed by nursing homes and clinics. Moreover, the rising healthcare expenditure in North-America on the back of new healthcare reforms is expected to bolster the demand for dengue vaccine • Geographically, Asia-Pacific and Latin-America region are expected to generate the largest market share of XX%, collectively by the end of 2024. The adoption of dengue vaccine on the back of government initiatives to eradicate dengue from dengue epidemic nations is one of the major which is creating a huge demand for dengue vaccine in these regions • Further, increasing spending by government authorities on research and development of advanced vaccinations along with rising dengue and their related health problems among the population are some of the major reason behind the spiked demand for dengue vaccine market. According to WHO, there are 390 million dengue cases worldwide each year, with number of cases reported increasing each year. In 2015, 2.35 million cases of dengue were reported in the Americas alone, of which 10,200 cases were diagnosed as severe dengue that led to 1,181 deaths. Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com

4. Major Players Presence-Regional Analysis Sample Request Low Penetration High Penetration Medium Penetration Source: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com

5. Global Dengue Vaccine Market Size (USD Billion) & Growth Analysis Global Dengue Vaccine Market Size (USD Billion)-2016-2024 Global Dengue Vaccine Market Y-O-Y Growth (%) Analysis-2016-2024 Sample Source: Goldstein Research Source: Goldstein Research • Europe dengue vaccine industry size is anticipated to expand at a compound annual growth rate of XX% during the forecast period i.e. 2016-2024. Further, dengue vaccine sales increased from XXXX units in 2015 to XXXX in 2016 • Takeda vaccinated the first subject in the Tetravalent Immunization against Dengue Efficacy Study (TIDES) on Sept 7, 2017. TIDES is now enrolling approximately 20,000 healthy children between the ages of four and 16 years living in dengue-endemic countries in Latin America and Asia • The progress of the dengue TIDES clinical trial, partnership with the Bill & Melinda Gates Foundation to eradicate polio, the recent initiation of the world’s first field efficacy trial for a norovirus vaccine, and work with the US Government to develop a Zika vaccine together demonstrate how dengue vaccine manufacturers are dedicated to developing and providing vaccines to protect people in need wherever they are Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com

6. Market Dynamics Sample Request Growth Drivers Growth Barriers Sample General Trend Highly Complex Moderately Complex Waived Vaccination Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com

7. Global Dengue Vaccine Market Share (%), 2016 & Market Size (USD Billion), By Region,2015 & 2016 Fig: 6-9 Global Dengue Vaccine Market Share (%) - By Region, 2016 Fig: 6-10 Global Dengue Vaccine Market Size (USD Billion) - By Region, 2015-2016 Sample Source: Goldstein Research Source: Goldstein Research • Asia-Pacific is expected to dominate the dengue vaccine market share of XX% by the end of the forecast period i.e. 2024 owing to the presence of emerging and developed economies such as India, China, Japan, Australia and others in dengue vaccine market • Merger & acquisition is the key strategy for the vendors of dengue market, for instance, Sanofi “Be a Wall against Dengue” disease education campaign to raise awareness on dengue prevention in Singapore, launched under partnership of Pasteur and Ya Kun Kaya Toast in conjunction with ASEAN Dengue Day (15 June 2017) Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com

8. Sample Request About Us Connect With Us: Published By: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com

9. Vision Value Visibility Sample Request About Us Based in U.S., Goldstein Research is a young business consulting and market research company with vast reach across America, Asia and parts of Europe and the Middle East. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions. With 30+ domain experts and 50+ employees working day and night to crunch numbers and bring out the best and detailed market reports and forecasts, we strive to enable you to foresee upcoming market challenges and develop a robust business model and strategies, which would add to your profitability and market visibility as a brand. Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Published By: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com

10. Vision Value Visibility Contact Us: For Research & Sales Related Queries +1-646-568-7747 +1-437-886-1181 +44-203-318-6627 +91-120-473-0422, +91-844-785-9968 sales@goldsteinresearch.com Corporate Office: 99 Wall Street, Suite No:- 527, New York, NY 10005 United States of America Office No:- 504, 5th Floor, C-51, BSI Business Park, Sector-62, Noida, PIN:- 201301 India  www.goldsteinresearch.com Published By: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com

11. Sample Request Thank you Connect With Us: Published By: Goldstein Research Copyright All Rights Reserved, Goldstein Research www.goldsteinresearch.com